Modeled onset time represents a PK→PD construct describing how absorption rate, absorption timing, solubility, gastric emptying, distribution loading, distribution geometry, and clearance shape rising-phase geometry for sildenafil and avanafil. "Onset time" refers strictly to modeled PK→PD behavior, not real-world timing. Absorption rate influences rising-phase steepness, absorption timing influences temporal alignment, solubility influences dissolution-driven availability, and gastric emptying influences input arrival. Distribution loading influences early central availability, while distribution geometry and clearance geometry influence how rapidly modeled material spreads or is removed. First-pass metabolism influences systemic fraction within the model. These PK parameters generate concentration-time trajectories. PD interpretation then transforms these trajectories through threshold placement, binding sensitivity, coupling geometry, and PD noise bands. Together, these variables define modeled onset-speed geometry. Link to speed overview.
Modeled onset-speed comparison describes how PK parameter sets generate different rising-phase trajectories. Faster modeled absorption steepens the rising phase, earlier absorption timing shifts the modeled curve position, solubility determines dissolution-driven availability, and gastric-emptying variation changes input arrival geometry. Distribution loading determines early central-compartment concentration patterns. Distribution geometry determines how absorbed material spreads through modeled compartments. Clearance geometry determines removal dynamics. First-pass metabolism determines the modeled systemic fraction, while concentration-dependent clearance can modify trajectory curvature. These mechanisms interact within mathematical representations: faster modeled absorption may combine with different clearance shapes, while earlier timing may combine with broader distribution geometry. PK geometry supplies the concentration trajectory that PD parameters transform. This comparison framework represents sildenafil and avanafil through modeled variables rather than observed timing. Link to onset sildenafil and onset avanafil.
PD geometry determines how modeled concentration trajectories become onset-time coordinates. Threshold placement defines where a PK curve intersects the modeled onset boundary. Binding sensitivity determines how concentration changes are translated into binding-related signal changes; greater modeled sensitivity can expand separation, while lower sensitivity can compress differences. Coupling geometry determines how binding transitions map into downstream PD signals; shallow slopes broaden transitions, while steep slopes compress transitions. PD noise bands modify the width of modeled interpretation regions. Because sildenafil and avanafil can be represented with different parameter combinations involving absorption rate, solubility, gastric emptying, distribution loading, Tmax geometry, and Cmax geometry, the resulting PK→PD mapping can expand or compress modeled onset-time differences. The resulting geometry describes mathematical relationships between parameters, not real-world onset prediction. Link to peak time.
PK onset geometry begins with the concentration-time trajectory generated by absorption and disposition parameters. Absorption rate influences the steepness of the modeled input phase, while solubility influences dissolution and available input formation. Absorption timing and gastric emptying determine when modeled material enters the absorption process. Distribution loading and distribution geometry influence early concentration placement between modeled compartments. Clearance geometry, first-pass metabolism, and bioavailability parameters influence the shape and magnitude of the systemic trajectory. Tmax geometry represents the modeled position of maximum concentration, while Cmax geometry represents the modeled peak concentration structure. Concentration-dependent clearance can alter the curvature of the trajectory as concentration changes. These PK variables create the input function used for onset-time comparison between sildenafil and avanafil. Link to absorption rate.
PK variability produces multiple possible modeled onset-time windows by changing parameter configurations rather than establishing fixed timing values. Differences in absorption window width can alter how gradually or rapidly input enters the modeled system. Distribution speed can modify early concentration movement between compartments, while metabolism speed and elimination speed can influence trajectory decline. Variations in Tmax geometry and Cmax geometry reshape the concentration profile that reaches the PD layer. A broader absorption window may produce a smoother rising phase, whereas a narrower input pattern may create a steeper modeled transition. These effects are interpreted through PK parameter space, allowing sildenafil and avanafil representations to be compared using geometric relationships. The resulting models describe parameter-driven trajectory differences. Link to distribution speed.
| PK Domain | Onset Interaction | Link |
|---|---|---|
| Absorption Rate | Steeper rising phase. | absorption rate |
| Distribution Geometry | Compartmental spread. | distribution speed |
| Clearance | Removal geometry. | elimination speed |
PD onset geometry begins when the modeled concentration trajectory is transformed into a signal boundary. Threshold placement determines the concentration coordinate where the modeled onset transition is assigned. Binding sensitivity controls how concentration changes are converted into binding-related changes within the model. Coupling geometry describes the relationship between binding and downstream signal formation. A steep coupling function can compress modeled transitions, while a shallow function can broaden them. PD noise bands represent uncertainty ranges around the modeled transition boundary. These parameters transform PK differences between sildenafil and avanafil into different onset-speed geometries. The resulting interpretation remains a mathematical PK→PD mapping based on parameter relationships. Link to pd speed.
Binding sensitivity, coupling geometry, and PD noise bands influence how modeled onset differences are represented after PK transformation. A concentration trajectory does not directly define the final modeled onset coordinate because PD parameters reshape the transition landscape. Higher modeled sensitivity can increase separation between concentration curves, while lower sensitivity can reduce visible differences. Coupling geometry determines whether small concentration changes create narrow or broad modeled transitions. Noise bands modify the range around these transitions by representing parameter uncertainty within the model. PK speed and PD speed therefore operate as connected layers: PK generates concentration geometry, and PD transforms that geometry into onset coordinates. Link to pk speed.
| PD Domain | Onset Effect | Link |
|---|---|---|
| Threshold Placement | Modeled boundary location. | pd speed |
| Binding Sensitivity | Amplification/compression. | onset variability comparison |
| Coupling Geometry | Slope-driven shaping. | peak variability comparison |
Modeled onset-time differences are determined by interactions between PK trajectory parameters and PD transformation parameters. PK variables include absorption rate, absorption timing, solubility, gastric emptying, distribution loading, distribution geometry, clearance geometry, first-pass metabolism, bioavailability, Tmax geometry, Cmax geometry, and concentration-dependent clearance. These variables define the concentration-time curve used in the model. PD variables then transform the curve through threshold placement, binding sensitivity, coupling geometry, and noise bands. The resulting onset coordinate represents a modeled transition point within a mathematical framework. For sildenafil and avanafil comparisons, differences arise from parameter configurations and their interactions. The construct describes geometric relationships between PK and PD variables rather than a fixed external timing measurement.
PK mechanisms shape modeled onset-time comparison by controlling how a concentration trajectory is generated. Absorption rate influences the slope of the rising phase, while absorption timing and gastric emptying influence when modeled input begins. Solubility affects dissolution-related availability, and absorption window width affects the duration of input formation. Distribution loading and distribution geometry influence concentration movement through modeled compartments. First-pass metabolism and bioavailability affect systemic fraction representation. Clearance geometry and concentration-dependent clearance influence trajectory shape after input. Tmax geometry describes the location of the modeled concentration maximum, while Cmax geometry describes the modeled peak structure. Together, these PK parameters create the concentration profile that is later interpreted through PD modeling layers.
PD mechanisms shape modeled onset speed by transforming concentration geometry into a defined transition region. Threshold placement determines where the concentration trajectory crosses the modeled onset boundary. Binding sensitivity determines how concentration differences are converted into binding-related differences. Coupling geometry defines the relationship between binding changes and downstream signal representation. PD noise bands create modeled ranges around transition points, allowing uncertainty to be represented mathematically. These PD components can expand or compress differences created by PK trajectories. In a sildenafil and avanafil comparison framework, the same concentration difference can produce different modeled onset geometry depending on the selected PD parameters. The result is a PK→PD interpretation model rather than a real-world timing statement.
Sildenafil and avanafil can differ in modeled onset geometry because a PK→PD model may assign different parameter values to absorption, distribution, metabolism, clearance, and PD transformation processes. Differences in absorption rate, absorption timing, solubility representation, gastric-emptying input, distribution loading, Tmax geometry, and Cmax geometry can create different concentration trajectories. PD parameters such as threshold placement, binding sensitivity, coupling geometry, and noise bands then transform those trajectories into onset coordinates. The resulting geometry reflects how selected parameters interact within the model structure. It does not represent a direct measurement of external timing. The comparison focuses on mathematical relationships between PK and PD components used to describe rising-phase behavior.
PK→PD mapping explains modeled onset-time differences by separating concentration generation from signal interpretation. PK parameters create the concentration trajectory through absorption, distribution, metabolism, and elimination processes. PD parameters then determine how that trajectory is converted into a modeled transition point. Threshold placement establishes the boundary, binding sensitivity modifies concentration-response translation, coupling geometry shapes the signal relationship, and PD noise bands define the interpretation range. A difference in modeled onset geometry can therefore emerge from either PK trajectory changes, PD transformation changes, or interactions between both layers. This framework allows sildenafil and avanafil to be represented through mechanistic parameter relationships without assigning external timing outcomes. The model describes geometry rather than prediction.